Journal
EXPERT OPINION ON DRUG DELIVERY
Volume 6, Issue 11, Pages 1207-1217Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1517/17425240903280414
Keywords
controlled release; drug delivery system; hollow capsule; layer-by-layer; stimuli-responsive; targeting
Categories
Funding
- Core Research for Evolutional Science and Technology (CREST)
Ask authors/readers for more resources
One of the key challenges in the field of bio-nanotechnology for drug delivery systems (DDS) is the development of nano- or micro-sized delivery carriers possessing both targeting functionalities for specific tissues or cells, and controlled release properties for encapsulated drug molecules, proteins and genes. Hollow capsules developed by layer-by-layer (LbL) assembly have attracted much attention over the past few years owing to their ability to be modified, their capacity to encapsulate a wide range of chemicals, and the variety of functionalities with which they can be enhanced. Current research on LbL capsules focuses on the development of functionalized capsules for specific targeting of cancer or immune cells, and on controlling their release properties by environmental stimuli. This review discusses recent advances in DDS using functional hollow capsules specific for the cellular and tissue-targeted delivery, as well as stimuli-responsive controlled release. DDS based on functional hollow capsules may contribute to the development of new nano-medicines.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available